Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Troussard

Showing results (301-310 of 365) with videos related to

Pageof 37
Sort By:
British Journal of Haematology|April 10, 2026
BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life studyUrbain Tauveron-Jalenques, Luca Inchiappa, Jérôme Paillassa, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2015
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based studyRoberta De Angelis, Pamela Minicozzi, Milena Sant, et al.
Journal of Clinical Pathology|October 13, 2016
Harmonisation of full blood count reports, recommendations of the French-speaking cellular haematology group (GFHC)Franck Trimoreau, Anne-Cécile Galoisy, Franck Geneviève, et al.
Cancer Research|January 7, 2006
Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survivalArmelle A Troussard, Paul C McDonald, Elizabeth D Wederell, et al.
Preventive Medicine|July 3, 2016
Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based studyFlorent Neumann, Jérémie Jégu, Christiane Mougin, et al.
Cancers|February 26, 2025
Health-Related Quality of Life in Long-Term Survivors of Non-Hodgkin Lymphoma: A French Population-Based StudyStephane Kroudia Wasse, Emerline Assogba, Sebastien Orazio, et al.
Leukemia & Lymphoma|October 31, 2006
Deciphering leukemic B-cell chronic lymphoproliferative disordersValérie Ugo, Nathalie Leporrier, Véronique Salaun, et al.
British Journal of Haematology|February 1, 2011
TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasmFabrice Jardin, Philippe Ruminy, Francoise Parmentier, et al.
Cancer Epidemiology|January 24, 2017
Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivorsMarie Moitry, Michel Velten, Brigitte Trétarre, et al.
Leukemia|February 1, 1997
Human herpes virus 8 (Kaposi's sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomasA Gessain, J Brière, C Angelin-Duclos, et al.
Pageof 37

Showing results (301-310 of 365) with videos related to

Sort By:
Pageof 37
British Journal of Haematology|April 10, 2026
BRAF inhibitor plus rituximab in classical hairy cell leukaemia: A retrospective multicentre real-life studyUrbain Tauveron-Jalenques, Luca Inchiappa, Jérôme Paillassa, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2015
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based studyRoberta De Angelis, Pamela Minicozzi, Milena Sant, et al.
Journal of Clinical Pathology|October 13, 2016
Harmonisation of full blood count reports, recommendations of the French-speaking cellular haematology group (GFHC)Franck Trimoreau, Anne-Cécile Galoisy, Franck Geneviève, et al.
Cancer Research|January 7, 2006
Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survivalArmelle A Troussard, Paul C McDonald, Elizabeth D Wederell, et al.
Preventive Medicine|July 3, 2016
Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based studyFlorent Neumann, Jérémie Jégu, Christiane Mougin, et al.
Cancers|February 26, 2025
Health-Related Quality of Life in Long-Term Survivors of Non-Hodgkin Lymphoma: A French Population-Based StudyStephane Kroudia Wasse, Emerline Assogba, Sebastien Orazio, et al.
Leukemia & Lymphoma|October 31, 2006
Deciphering leukemic B-cell chronic lymphoproliferative disordersValérie Ugo, Nathalie Leporrier, Véronique Salaun, et al.
British Journal of Haematology|February 1, 2011
TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasmFabrice Jardin, Philippe Ruminy, Francoise Parmentier, et al.
Cancer Epidemiology|January 24, 2017
Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivorsMarie Moitry, Michel Velten, Brigitte Trétarre, et al.
Leukemia|February 1, 1997
Human herpes virus 8 (Kaposi's sarcoma herpes virus) and malignant lymphoproliferations in France: a molecular study of 250 cases including two AIDS-associated body cavity based lymphomasA Gessain, J Brière, C Angelin-Duclos, et al.
Pageof 37